The FDA oversees approval and regulation of medications like mifepristone (used in medication abortion), HIV-prevention drugs like PrEP, and contraceptive options from pills to IUDs. Research confirms mifepristone's 99% safety record in abortion care, yet political pressures often override medical evidence in FDA decisions.
Recent studies show FDA commissioners significantly impact health equity. Timely approval of gender-affirming medications, accurate condom efficacy labeling, and expanded over-the-counter birth control access all depend on leadership prioritizing science over ideology.
Mifepristone safety is supported by 20+ years of medical evidence.
Why This Matters
Sexual health isn't partisan—it's about bodily autonomy. Delays in approving morning-after pills for all weights, restricting vasectomy options, or creating barriers to STD test kits disproportionately harm marginalized communities. Evidence-based leadership ensures lifesaving tools reach those who need them.
During the 2022 mifepristone legal challenges, FDA's scientific integrity preserved access to this WHO-essential medication. Future decisions on breast cancer risk apps, at-home STI tests, and testosterone accessibility will similarly impact millions.
What You Can Do
Stay informed about FDA public comment periods for sexual health products—like recent OTC birth control petitions. Advocate for transparent approval processes free from non-medical restrictions.
Support organizations tracking FDA decisions affecting LGBTQ+ healthcare and reproductive justice. Voting records of Senate confirmation committees directly influence who oversees these critical health decisions.
Learn More
Related topics on The Nookie Nook: lgbtq · reproductive
